Should You. Not Can You.
Rimsys Market Access turns a six-month guess into a confident answer. An AI-native solution built for the regulatory and commercial teams who need to know before they commit to a new market what it will actually take, cost, and require to bring a product into it. Once approved, that actionable plan hands straight to Rimsys RIM for controlled execution.
This is way faster than what we can do. This feels like the magic wand that says: regulatory is not a mystery anymore. We are finally demystifying regulatory."
Enterprise Global Medtech Manufacturer
Problem
The Black Box Problem
Manual, market-by-market research turns every product launch into a guessing game, one that costs regulatory teams their time, commercial teams their revenue, companies their growth goals, and patients access to the medical devices they need.
Bottleneck
One Market, One Expert
Regulatory knowledge for a given market lives with one person or an outside distributor, not in any shared system. When that partner is unavailable, everyone else waits.
UNCERTAINTY
Opaque Until It's Too Late
Regulatory requirements stay unpredictable until a team is already deep into the process. Even with perfect data, a portion of every submission still comes down to reviewer interpretation no one can fully de-risk.
Cost
A Model That Doesn't Scale
Running this today costs leading manufacturers upward of $30 million a year in local market specialists, a cost that only grows as the portfolio does.
URGENCY
Every Delay Is Lost Revenue
Missed renewals, re-justified business cases, and market windows that close before a decision gets made all land directly on the P&L of the team accountable for growth.
Solution
Confidence to Decide
Market Access is a global market planning platform built for medtech regulatory and commercial teams together. It classifies the product, maps the pathway, and builds the plan, giving teams the confidence to commit or walk away fast, not just information to review.
Turn a black box into a decision you can defend, in hours instead of months.
Put an expert-level answer for any market in the hands of anyone who needs one, not just the specialist who holds it.
Ground every answer in a curated regulatory corpus and your own Rimsys data, each one traceable to its source.
Rely on a product shaped by regulatory experts and validated with the enterprise medtech manufacturers who live this work.
Run the strategy, budgeting, and analysis market entry demands, then carry the plan straight into Rimsys RIM to execute.
Rimsys Platform
Two teams work from the same source-linked plan. Regulatory authors it, commercial acts on it, and neither is left assembling an answer from scratch.
Get visibility into a market decision before committing budget or resources to finding out the hard way. Instead of waiting on a regulatory body's response, get an instant, expert-level read, classification, pathway, timeline, and cost, packaged as a clear go or no-go signal for leadership.
- Get ahead of the wait
Know the shape of a market's regulatory pathway without routing through whoever happens to hold that market's knowledge or waiting months for a regulatory body's response.
- Walk into the conversation with an answer, not a guess
Bring leadership a go or no-go read backed by the specific regulation behind it, not just a hunch.
- Stop re-justifying the same market case
Build your business case once, from a plan that already accounts for cost and timeline, not market by market from scratch.
- Protect the revenue window
See the pathway early enough to act before a market opportunity closes.
- Bring regulatory something they can move on immediately
Hand off a plan already sourced and structured for review, not a request that starts their work from zero.
Get the manual dossier work off your plate. Every classification, pathway, timeline, and requirement comes back linked to the regulation behind it, so you review evidence and don't take someone's word for it. Nothing moves to execution without sign-off.
- Review, don't assemble
Get a sourced plan built from current regulatory data instead of piecing one together from a distributor's word and an incomplete document trail.
- Catch it before it's a deficiency letter
Surface the gaps and requirements likely to trip up a submission before it ever goes out the door.
- Get your time back from document-shuttling
Spend it on the judgment calls only a regulatory professional can make, not on moving files between people.
- Stay the final word
Every plan holds at a human review checkpoint before anything moves to execution, so accountability never leaves your hands.
- Trust the source, not the messenger
Every requirement traces back to the specific regulation behind it, so you're verifying the regulation, not taking someone else's classification on faith.
Why Market Access?
We answer the question other tools stop short of asking: not just whether you can enter a market, but whether you should.
Most tools in this space stop at classification and pathway. Market Access goes further, grounded in a curated regulatory corpus rather than the open web, with every answer traceable back to the specific regulation behind it and a human reviewing the work before anything moves forward.
That's what turns regulatory approval from a black box into a decision a team can see coming, in hours instead of months.
The plan doesn't stop at a report. It hands directly into the Rimsys RIM platform for controlled execution, so the decision and the work of acting on it live in one continuous system, not two disconnected tools.
Backed by a company already trusted by 6 of the top 12 global medtech manufacturers, Market Access gives regulatory and commercial teams a plan they can defend, not just an answer they have to take on faith.
See how Rimsys AI transforms regulatory execution across submissions, impact assessment, and global compliance workflows.
FAQs
Market Access is a global market planning platform that helps medtech manufacturers decide whether, when, and how to enter a new market before committing budget or resources to find out. For any market, it returns product classification, regulatory pathway, timeline, and cost, each traceable back to the specific regulation behind it, then hands the resulting plan to the Rimsys RIM platform to execute.
Rimsys RIM is the platform that executes your regulatory work: registrations, submissions, and ongoing compliance. Market Access is the planning step that comes before that. It helps you decide whether a market is worth entering and what it will take to get there, then hands the resulting plan into Rimsys RIM once you're ready to act.
No. Market Access is the market planning platform and Rimsys RIM is the controlled execution platform, and each can stand on its own. If you use both, plans flow seamlessly from Market Access into Rimsys RIM for execution.
Market Access is purpose-built for medtech regulatory complexity, drawing on a curated corpus spanning more than 150 markets. It also handles adjacent product designations, such as consumer, cosmetic, and combination products, for cases where a product crosses those lines.
Market Manager Agents hold the regulatory knowledge for a specific market, the pathways, requirements, and documentation, the way an in-house market manager or distributor would. When a task, like product classification or budget analysis, needs a market-specific answer, it draws on that agent's knowledge to complete it.
Both. You can run a single task for one market, like a product classification, or run a full workflow, like a global rollout plan, that pulls together many agents to produce one end-to-end plan.
A completed plan includes classification per market, regulatory pathway, timeline, cost estimates, competitive pathway comparisons, a risk register, and a proposed task list. It's delivered as a one-page executive summary with a go or no-go read, plus a detailed, source-linked dossier for regulatory teams to review and redline.
Yes. Every workflow includes a human review checkpoint before execution, and a regulatory professional can directly edit and refine the plan before it's finalized.